Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Εμφάνιση άλλων εκδόσεων (1)

PURPOSE: Dihydroartemisinin-piperaquine (DP) is a fixed-dose artemisinin-based combination treatment. Field pharmacokinetic studies would be simplified and facilitated by being able to use small volume capillary assays rather than venous blood. The aim of this study was to describe the relationship...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Ashley, E, Stepniewska, K, Lindegardh, N, Annerberg, A, Tarning, J, Mcgready, R, Phaiphun, L, Singhasivanon, P, White, N, Nosten, F
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2010

Παρόμοια τεκμήρια

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
ανά: Ashley, E, κ.ά.
Έκδοση: (2010)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
ανά: Tarning, J, κ.ά.
Έκδοση: (2007)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
ανά: Rijken, M, κ.ά.
Έκδοση: (2011)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
ανά: Tarning, J, κ.ά.
Έκδοση: (2008)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
ανά: Adam, I, κ.ά.
Έκδοση: (2012)

Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
ανά: Saito, M, κ.ά.
Έκδοση: (2024)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2014)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2009)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
ανά: Mcgready, R, κ.ά.
Έκδοση: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
ανά: McGready, R, κ.ά.
Έκδοση: (2009)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
ανά: Mytton, O, κ.ά.
Έκδοση: (2007)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
ανά: Tarning, J, κ.ά.
Έκδοση: (2012)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
ανά: Ashley, E, κ.ά.
Έκδοση: (2004)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
ανά: Zongo, I, κ.ά.
Έκδοση: (2014)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
ανά: Annerberg, A, κ.ά.
Έκδοση: (2011)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
ανά: Annerberg, A, κ.ά.
Έκδοση: (2011)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
ανά: Hoglund, R, κ.ά.
Έκδοση: (2012)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
ανά: Ashley, E, κ.ά.
Έκδοση: (2007)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
ανά: Ashley, E, κ.ά.
Έκδοση: (2007)

A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
ανά: Ashley, E, κ.ά.
Έκδοση: (2005)

Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
ανά: Ashley, E, κ.ά.
Έκδοση: (2006)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
ανά: Issaka Zongo, κ.ά.
Έκδοση: (2014-01-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
ανά: Hoglund Richard M, κ.ά.
Έκδοση: (2012-11-01)

Erratum:The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria(European Journal of Clinical Pharmacology (2006) 62 (1021-1031) DOI: 10.1007/s00228-006-0199-7)
ανά: Mcgready, R, κ.ά.
Έκδοση: (2009)

Quantification of the antimalarial piperaquine in plasma.
ανά: Tarning, J, κ.ά.
Έκδοση: (2008)

Pitfalls in estimating piperaquine elimination.
ανά: Tarning, J, κ.ά.
Έκδοση: (2005)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
ανά: Rijken, M, κ.ά.
Έκδοση: (2007)

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
ανά: Mcgready, R, κ.ά.
Έκδοση: (2008)

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
ανά: Mcgready, R, κ.ά.
Έκδοση: (2006)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
ανά: Jamsen, K, κ.ά.
Έκδοση: (2011)

Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
ανά: Creek, D, κ.ά.
Έκδοση: (2013)

Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
ανά: Rijken, M, κ.ά.
Έκδοση: (2008)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
ανά: Smithuis, F, κ.ά.
Έκδοση: (2006)

In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
ανά: Ashley, E, κ.ά.
Έκδοση: (2006)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
ανά: Lwin, K, κ.ά.
Έκδοση: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
ανά: Lwin, K, κ.ά.
Έκδοση: (2012)